Related Experiment Video
Updated: Jan 21, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Signaling Pathways in Leukemic Stem Cells
Lindsay M Gurska1,2, Kristina Ames1,2, Kira Gritsman3,4,5
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
Insights
Hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) share signaling pathways. This review highlights differences in these pathways, like PI3K/AKT/mTOR, WNT, NOTCH, and TGFβ, to identify LSC-specific therapeutic targets.
Area of Science:
- Cellular biology
- Molecular oncology
- Stem cell research
Background:
- Hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) share common signaling pathways essential for their survival.
- Understanding these shared pathways is crucial for developing targeted therapies against leukemia.
Purpose of the Study:
- To review key signaling pathways, including PI3K/AKT/mTOR, WNT/β-catenin, NOTCH, and TGFβ, in both HSCs and LSCs.
- To identify differences in pathway function between HSCs and LSCs to pinpoint LSC-specific therapeutic vulnerabilities.
- To explore potential crosstalk between signaling pathways impacting LSC function.
Main Methods:
- Literature review focusing on signaling pathways in HSCs and LSCs.
- Comparative analysis of pathway regulation and function in normal versus malignant stem cells.
- Identification of therapeutic targets based on pathway dysregulation in LSCs.
Main Results:
- The PI3K/AKT/mTOR pathway is a central focus, with its regulators and effectors playing critical roles in both HSCs and LSCs.
- Distinct roles of WNT/β-catenin, NOTCH, and TGFβ pathways in LSC maintenance and survival compared to HSCs were identified.
- Significant crosstalk between various signaling pathways influencing LSC behavior was highlighted.
Conclusions:
- Targeting shared signaling pathways with an emphasis on their differential roles in LSCs presents a promising strategy for leukemia therapy.
- Understanding pathway crosstalk is essential for developing effective and specific LSC-targeting treatments.
- Further research into these pathways could lead to novel therapeutic interventions for hematologic malignancies.
Abstract:
Hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) utilize many of the same signaling pathways for their maintenance and survival. In this review, we will focus on several signaling pathways whose roles have been extensively studied in both HSCs and LSCs. Our main focus will be on the PI3K/AKT/mTOR pathway and several of its regulators and downstream effectors. We will also discuss several other signaling pathways of particular importance in LSCs, including the WNT/β-catenin pathway, the NOTCH pathway, and the TGFβ pathway. For each of these pathways, we will emphasize differences in how these pathways operate in LSCs, compared to their function in HSCs, to highlight opportunities for the specific therapeutic targeting of LSCs. We will also highlight areas of crosstalk between multiple signaling pathways that may affect LSC function.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
04:06Efficient and Cost Effective Electroporation Method to Study Primary Cilium-Dependent Signaling Pathways in the Granule Cell Precursor
Published on: November 30, 2021
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway